Status
Conditions
About
The purpose of this study is to collect information and bone marrow, blood, saliva, cheek cells and skin to be used in the laboratory to assist the sponsor in identifying a new way of treating MDS.
Full description
Goals of the study:
The purpose of this study is to collect the blood and marrow samples, and non-involved fibroblasts, that are required to identify the unique, personalized array of mutation-driven neoantigens that are expressed by the subject's MDS cells and to assess the feasibility of immunizing and expanding one or more of the patient's T cells ex vivo for investigation of their use as adoptive cellular immunotherapy.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Patients must meet the following initial inclusion criteria:
Patient exclusion criteria:
Loading...
Central trial contact
Rafael Bejar, MD; Tiffany Tanaka, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal